Results 141 to 150 of about 406,477 (211)

Prevalence and changing antimicrobial resistance profiles of Shigella spp. isolated from diarrheal patients in Kolkata during 2011-2019. [PDF]

open access: yesPLoS Negl Trop Dis
Bose P   +10 more
europepmc   +1 more source

Genome-Wide Investigation Reveals Potential Therapeutic Targets in Shigella spp. [PDF]

open access: yesBiomed Res Int
Hossain MA   +7 more
europepmc   +1 more source

Mutational convergence acts as a major player in adaptive parallel evolution of Shigella spp. [PDF]

open access: yesSci Rep, 2019
Thomas AK   +6 more
europepmc   +1 more source

Complete Genome Sequence of a Novel Myoviridae Phage, SfΦ01, Infecting Shigella spp. [PDF]

open access: yesMicrobiol Resour Announc, 2019
Kitajima M, Ishii S, Takagi T, Okabe S.
europepmc   +1 more source

Correction: The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp.

open access: yesElife, 2022
Fernández Álvaro E   +23 more
europepmc   +1 more source

Burden, Antibiotic Resistance, and Clonality of Shigella spp. Implicated in Community-Acquired Acute Diarrhoea in Lilongwe, Malawi. [PDF]

open access: yesTrop Med Infect Dis, 2021
Phiri AFND   +6 more
europepmc   +1 more source

Safety and Tolerability of ShigActive™, a <i>Shigella</i> spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial. [PDF]

open access: yesAntibiotics (Basel)
Chen WH   +14 more
europepmc   +1 more source

Temporal GWAS identifies a widely distributed novel protein Stv contributing to pathogen success in Shigella spp

open access: yes, 2022
De Silva PM   +8 more
europepmc   +1 more source

Genome-wide association studies of Shigella spp. and Enteroinvasive Escherichia coli isolates demonstrate an absence of genetic markers for prediction of disease severity. [PDF]

open access: yesBMC Genomics, 2020
Hendriks ACA   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy